http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2010098344-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-16 |
| filingDate | 2010-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2010098344-A1 |
| titleOfInvention | Tricyclic pyrazolopyrimidine derivatives |
| abstract | To provide a novel compound that inhibits the action of HSP90, particularly a novel compound that inhibits the function of HSP90 as a chaperone protein and has antitumor activity. The present invention relates to a pyrazolopyrimidine compound represented by formula (1) having various substituents, which inhibits the ATPase activity of HSP90 and has antitumor activity, and an HSP90 inhibitor comprising a compound represented by formula (1) , A pharmaceutical comprising the compound represented by formula (1), an anticancer agent comprising the compound represented by formula (1), a pharmaceutical composition comprising the compound represented by formula (1) and the formula (1) A method for treating cancer using the compound is provided. |
| priorityDate | 2009-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 401.